Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF

Immunity

Volumn 20, Issue 4, 2004, Pages 441-453

  Lesley, Robin ^a   Xu, Ying ^a   Kalled, Susan L ^b   Hess, Donna M ^b   Schwab, Susan R ^a   Shu, Hong Bing ^c   Cyster, Jason G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BIOGEN   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CYTOKINE; CYTOKINE BAFF; CYTOKINE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOTRANSFERASE; PIM 2 KINASE; PROTEIN P52; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CELL COMPARTMENTALIZATION; CELL DEATH; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; KIDNEY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNE TOLERANCE; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1842633887     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(04)00079-2     Document Type: Article

References (80)

1. Adelstein S., Pritchard-Briscoe H., Anderson T.A., Crosbie J., Gammon G., Loblay R.H., Basten A., Goodnow C.C. Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science. 251:1991;1223-1225.
2. Allen J.D., Berns A. Complementation tagging of cooperating oncogenes in knockout mice. Semin. Cancer Biol. 7:1996;299-306.
3. Allman D., Lindsley R.C., DeMuth W., Rudd K., Shinton S.A., Hardy R.R. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 167:2001;6834-6840.
4. August C.S., Hathaway W.E. Hematological disorders. Stiehm E.R. Immunological disorders in infants and children. 1989;634-665 W.B. Saunders Company, Philadelphia.
5. Avery D.T., Kalled S.L., Ellyard J.I., Ambrose C., Bixler S.A., Thien M., Brink R., Mackay F., Hodgkin P.D., Tangye S.G. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J. Clin. Invest. 112:2003;286-297.
6. Batten M., Groom J., Cachero T.G., Qian F., Schneider P., Tschopp J., Browning J.L., Mackay F. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192:2000;1453-1466.
7. Benschop R.J., Aviszus K., Zhang X., Manser T., Cambier J.C., Wysocki L.J. Activation and anergy in bone marrow B cells of a novel immunoglobulin transgenic mouse that is both hapten specific and autoreactive. Immunity. 14:2001;33-43.
8. Bouillet P., Metcalf D., Huang D.C., Tarlinton D.M., Kay T.W., Kontgen F., Adams J.M., Strasser A. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 286:1999;1735-1738.
9. Bouillet P., Purton J.F., Godfrey D.I., Zhang L.C., Coultas L., Puthalakath H., Pellegrini M., Cory S., Adams J.M., Strasser A. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature. 415:2002;922-926.
10. Claudio E., Brown K., Park S., Wang H., Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3:2002;958-965.
11. Cook M.C., Basten A., Fazekas de St Groth B. Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy. J. Exp. Med. 186:1997;631-643.
12. Cyster J.G. Signaling thresholds and interclonal competition in preimmune B-cell selection. Immunol. Rev. 156:1997;87-101.
13. Cyster J.G., Goodnow C.C. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity. 3:1995;691-701.
14. Cyster J.G., Hartley S.B., Goodnow C.C. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature. 371:1994;389-395.
15. Davey G.M., Kurts C., Miller J.F., Bouillet P., Strasser A., Brooks A.G., Carbone F.R., Heath W.R. Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J. Exp. Med. 196:2002;947-955.
16. Do R.K., Hatada E., Lee H., Tourigny M.R., Hilbert D., Chen-Kiang S. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J. Exp. Med. 192:2000;953-964.
17. Ekland E.H., Forster R., Lipp M., Cyster J.G. Requirements for follicular exclusion and competitive elimination of autoantigen binding B cells. J. Immunol. 172:2004;4700-4708.
18. Enders A., Bouillet P., Puthalakath H., Xu Y., Tarlinton D.M., Strasser A. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J. Exp. Med. 198:2003;1119-1126.
19. Fox C.J., Hammerman P.S., Cinalli R.M., Master S.R., Chodosh L.A., Thompson C.B. The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev. 17:2003;1841-1854.
20. Fu Y.-X., Chaplin D.D. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 17:1999;399-433.
21. Fulcher D.A., Basten A. Reduced life span of anergic self-reactive B cells in a double-transgenic model. J. Exp. Med. 179:1994;125-134.
22. Goodnow C.C. Pathways for self-tolerance and the treatment of autoimmune diseases. Lancet. 357:2001;2115-2121.
23. Goodnow C.C., Crosbie J., Adelstein S., Lavoie T.B., Smith-Gill S.J., Brink R.A., Pritchard-Briscoe H., Wotherspoon J.S., Loblay R.H., Raphael K.et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature. 334:1988;676-682.
24. Gorelik L., Gilbride K., Dobles M., Kalled S.L., Zandman D., Scott M.L. Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. J. Exp. Med. 198:2003;937-945.
25. Gorelik L., Cutler A.H., Thill G., Miklasz S.D., Shea D.E., Ambrose C., Bixler S.A., Su L., Scott M.L., Kalled S.L. Cutting edge. BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function J. Immunol. 172:2004;762-766.
26. Groom J., Kalled S.L., Cutler A.H., Olson C., Woodcock S.A., Schneider P., Tschopp J., Cachero T.G., Batten M., Wheway J.et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J. Clin. Invest. 109:2002;59-68.
27. Gross J.A., Johnston J., Mudri S., Enselman R., Dillon S.R., Madden K., Xu W., Parrish-Novak J., Foster D., Lofton-Day C.et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 404:2000;995-999.
28. Gross J.A., Dillon S.R., Mudri S., Johnston J., Littau A., Roque R., Rixon M., Schou O., Foley K.P., Haugen H.et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking BLyS. Immunity. 15:2001;289-302.
29. Gunn M.D., Ngo V.N., Ansel K.M., Ekland E.H., Cyster J.G., Williams L.T. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature. 391:1998;799-803.
30. Harless S.M., Lentz V.M., Sah A.P., Hsu B.L., Clise-Dwyer K., Hilbert D.M., Hayes C.E., Cancro M.P. Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers. Curr. Biol. 11:2001;1986-1989.
31. Hatada E.N., Do R.K., Orlofsky A., Liou H.C., Prystowsky M., MacLennan I.C., Caamano J., Chen-Kiang S. NF-kappaB1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappaB2 p100 to p52 in quiescent mature B cells. J. Immunol. 171:2003;761-768.
32. Healy J.I., Dolmetsch R.E., Timmerman L.A., Cyster J.G., Thomas M.L., Crabtree G.R., Lewis R.S., Goodnow C.C. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity. 6:1997;419-428.
33. Hildeman D.A., Zhu Y., Mitchell T.C., Bouillet P., Strasser A., Kappler J., Marrack P. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity. 16:2002;759-767.
34. Hsu B.L., Harless S.M., Lindsley R.C., Hilbert D.M., Cancro M.P. Cutting edge. BLyS enables survival of transitional and mature B cells through distinct mediators J. Immunol. 168:2002;5993-5996.
35. Kanakaraj P., Migone T.S., Nardelli B., Ullrich S., Li Y., Olsen H.S., Salcedo T.W., Kaufman T., Cochrane E., Gan Y.et al. BLyS binds to B cells with high affinity and induces activation of the transcription factors NF-kappaB and ELF-1. Cytokine. 13:2001;25-31.
36. Karagogeos D., Rosenberg N., Wortis H.H. Early arrest of B cell development in nude, X-linked immune-deficient mice. Eur. J. Immunol. 16:1986;1125-1130.
37. Karpusas M., Cachero T.G., Qian F., Boriack-Sjodin A., Mullen C., Strauch K., Hsu Y.M., Kalled S.L. Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes. J. Mol. Biol. 315:2002;1145-1154.
38. Kayagaki N., Yan M., Seshasayee D., Wang H., Lee W., French D.M., Grewal I.S., Cochran A.G., Gordon N.C., Yin J.et al. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity. 17:2002;515-524.
39. Khare S.D., Sarosi I., Xia X.Z., McCabe S., Miner K., Solovyev I., Hawkins N., Kelley M., Chang D., Van G.et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. USA. 97:2000;3370-3375.
40. Kim H.M., Yu K.S., Lee M.E., Shin D.R., Kim Y.S., Paik S.G., Yoo O.J., Lee H., Lee J.O. Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation. Nat. Struct. Biol. 10:2003;342-348.
41. Lang J., Nemazee D. B cell clonal elimination induced by membrane-bound self-antigen may require repeated antigen encounter or cell competition. Eur. J. Immunol. 30:2000;689-696.
42. Lentz V.M., Cancro M.P., Nashold F.E., Hayes C.E. Bcmd governs recruitment of new B cells into the stable peripheral B cell pool in the A/WySnJ mouse. J. Immunol. 157:1996;598-606.
43. Lentz V.M., Hayes C.E., Cancro M.P. Bcmd decreases the life span of B-2 but not B-1 cells in A/WySnJ mice. J. Immunol. 160:1998;3743-3747.
44. Li J., Peet G.W., Balzarano D., Li X., Massa P., Barton R.W., Marcu K.B. Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition. J. Biol. Chem. 276:2001;18579-18590.
45. Liu Y., Xu L., Opalka N., Kappler J., Shu H.B., Zhang G. Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands. Cell. 108:2002;383-394.
46. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., Tschopp J., Browning J.L. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190:1999;1697-1710.
47. Mackay I.R., Groom J., Mackay C.R. Levels of BAFF in serum in primary biliary cirrhosis and autoimmune diabetes. Autoimmunity. 35:2002;551-553.
48. Mackay F., Schneider P., Rennert P., Browning J. Baff and april. a tutorial on b cell survival Annu. Rev. Immunol. 21:2003;231-264.
49. Mandik-Nayak L., Bui A., Noorchashm H., Eaton A., Erikson J. Regulation of anti-double-stranded DNA B cells in nonautoimmune mice. localization to the T-B interface of the splenic follicle J. Exp. Med. 186:1997;1257-1267.
50. Mandik-Nayak L., Seo S., Eaton-Bassiri A., Allman D., Hardy R.R., Erikson J. Functional consequences of the developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J. Immunol. 164:2000;1161-1168.
51. Mariette X., Roux S., Zhang J., Bengoufa D., Lavie F., Zhou T., Kimberly R. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann. Rheum. Dis. 62:2003;168-171.
52. Mason D.Y., Jones M., Goodnow C.C. Development and follicular localization of tolerant B lymphocytes in lysozyme/anti-lysozyme IgM/IgD transgenic mice. Int. Immunol. 4:1992;163-175.
53. Miller D.J., Hayes C.E. Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ mice. Eur. J. Immunol. 21:1991;1123-1130.
54. Miosge L.A., Blasioli J., Blery M., Goodnow C.C. Analysis of an ethylnitrosourea-generated mouse mutation defines a cell intrinsic role of nuclear factor kappaB2 in regulating circulating B cell numbers. J. Exp. Med. 196:2002;1113-1119.
55. Moore P.A., Belvedere O., Orr A., Pieri K., LaFleur D.W., Feng P., Soppet D., Charters M., Gentz R., Parmelee D.et al. Blys. member of the tumor necrosis factor family and b lymphocyte stimulator Science. 285:1999;260-263.
56. Mukhopadhyay A., Ni J., Zhai Y., Yu G.L., Aggarwal B.B. Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J. Biol. Chem. 274:1999;15978-15981.
57. Nemazee D. Receptor selection in B and T lymphocytes. Annu. Rev. Immunol. 18:2000;19-51.
58. Ngo V.N., Korner H., Gunn M.D., Schmidt K.N., Riminton D.S., Cooper M.D., Browning J.L., Sedgwick J.D., Cyster J.G. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 189:1999;403-412.
59. O'Connor B.P., Raman V.S., Erickson L.D., Cook W.J., Weaver L.K., Ahonen C., Lin L.L., Mantchev G.T., Bram R.J., Noelle R.J. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199:2004;91-98.
60. Pelletier M., Thompson J.S., Qian F., Bixler S.A., Gong D., Cachero T., Gilbride K., Day E., Zafari M., Benjamin C.et al. Comparison of soluble decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFF. J. Biol. Chem. 278:2003;33127-33133.
61. Phan T.G., Amesbury M., Gardam S., Crosbie J., Hasbold J., Hodgkin P.D., Basten A., Brink R. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J. Exp. Med. 197:2003;845-860.
62. Rolink A.G., Tschopp J., Schneider P., Melchers F. BAFF is a survival and maturation factor for mouse B cells. Eur. J. Immunol. 32:2002;2004-2010.
63. Schiemann B., Gommerman J.L., Vora K., Cachero T.G., Shulga-Morskaya S., Dobles M., Frew E., Scott M.L. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science. 293:2001;2111-2114.
64. Schmidt K.N., Cyster J.G. Follicular exclusion and rapid elimination of hen egg lysozyme autoantigen-binding B cells are dependent on competitor B cells, but not on T cells. J. Immunol. 162:1999;284-291.
65. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H.et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189:1999;1747-1756.
66. Schneider P., Takatsuka H., Wilson A., Mackay F., Tardivel A., Lens S., Cachero T.G., Finke D., Beermann F., Tschopp J. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J. Exp. Med. 194:2001;1691-1697.
67. Shu H.B., Hu W.H., Johnson H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J. Leukoc. Biol. 65:1999;680-683.
68. Smith S.H., Cancro M.P. Cutting edge. B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors J. Immunol. 170:2003;5820-5823.
69. Thompson J.S., Schneider P., Kalled S.L., Wang L., Lefevre E.A., Cachero T.G., MacKay F., Bixler S.A., Zafari M., Liu Z.Y.et al. BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J. Exp. Med. 192:2000;129-135.
70. Thompson J.S., Bixler S.A., Qian F., Vora K., Scott M.L., Cachero T.G., Hession C., Schneider P., Sizing I.D., Mullen C.et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science. 293:2001;2108-2111.
71. Tribouley C., Wallroth M., Chan V., Paliard X., Fang E., Lamson G., Pot D., Escobedo J., Williams L.T. Characterization of a new member of the TNF family expressed on antigen presenting cells. Biol. Chem. 380:1999;1443-1447.
72. Varfolomeev E., Kischkel F., Martin F., Seshasayee D., Wang H., Lawrence D., Olsson C., Tom L., Erickson S., French D.et al. APRIL-deficient mice have normal immune system development. Mol. Cell. Biol. 24:2004;997-1006.
73. von Bulow G.U., van Deursen J.M., Bram R.J. Regulation of the T-independent humoral response by TACI. Immunity. 14:2001;573-582.
74. Wardemann H., Yurasov S., Schaefer A., Young J.W., Meffre E., Nussenzweig M.C. Predominant autoantibody production by early human B cell precursors. Science. 301:2003;1374-1377.
75. Xu S., Lam K.P. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Mol. Cell. Biol. 21:2001;4067-4074.
76. Xu L.G., Wu M., Hu J., Zhai Z., Shu H.B. Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1. J. Leukoc. Biol. 72:2002;410-416.
77. Yan M., Brady J.R., Chan B., Lee W.P., Hsu B., Harless S., Cancro M., Grewal I.S., Dixit V.M. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr. Biol. 11:2001;1547-1552. a.
78. Yan M., Wang H., Chan B., Roose-Girma M., Erickson S., Baker T., Tumas D., Grewal I.S., Dixit V.M. Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol. 2:2001;638-643. b.
79. Yan B., Zemskova M., Holder S., Chin V., Kraft A.S., Koskinen P.J., Lilly M.B. The PIM-2 kinase phosphorylates BAD on serine-112 and reverses BAD-induced cell death. J. Biol. Chem. 278:2003;45358-45367.
80. Zhang J., Roschke V., Baker K.P., Wang Z., Alarcon G.S., Fessler B.J., Bastian H., Kimberly R.P., Zhou T. Cutting edge. a role for B lymphocyte stimulator in systemic lupus erythematosus J. Immunol. 166:2001;6-10.